ProQR Therapeutics N.V. buy Chardan Capital
Start price
10.05.24
/
50%
€1.86
Target price
10.05.25
€2.32
Performance (%)
-7.15%
Price
26.07.24
€1.73
Summary
This prediction is currently active. With a performance of -7.15%, the BUY prediction by Chardan_Capital is trending in the wrong direction. This prediction currently runs until 10.05.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
ProQR Therapeutics N.V. | 7.267% | 7.267% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by Chardan_Capital for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $2.50 price target on the stock.
Ratings data for PRQR provided by MarketBeat
Stopped prediction by Chardan_Capital for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.27
08.11.23
08.11.23
€1.87
08.11.24
08.11.24
36.41%
26.07.24
26.07.24